Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 117

1.

The classical complement pathway in transplantation: unanticipated protective effects of C1q and role in inductive antibody therapy.

Csencsits K, Burrell BE, Lu G, Eichwald EJ, Stahl GL, Bishop DK.

Am J Transplant. 2008 Aug;8(8):1622-30. doi: 10.1111/j.1600-6143.2008.02295.x. Epub 2008 Jun 28.

2.

Transforming growth factor beta-induced connective tissue growth factor and chronic allograft rejection.

Csencsits K, Wood SC, Lu G, Faust SM, Brigstock D, Eichwald EJ, Orosz CG, Bishop DK.

Am J Transplant. 2006 May;6(5 Pt 1):959-66.

3.

Graft rejection mediated by CD4+ T cells via indirect recognition of alloantigen is associated with a dominant Th2 response.

Csencsits K, Wood SC, Lu G, Magee JC, Eichwald EJ, Chang CH, Bishop DK.

Eur J Immunol. 2005 Mar;35(3):843-51.

4.

Requirement for donor and recipient CD40 expression in cardiac allograft rejection: induction of Th1 responses and influence of donor-derived dendritic cells.

Nathan MJ, Mold JE, Wood SC, Csencsits K, Lu G, Eichwald EJ, Bishop DK.

J Immunol. 2004 Jun 1;172(11):6626-33.

5.

Nuclear factor kappaB inhibitors induce adhesion-dependent colon cancer apoptosis: implications for metastasis.

Scaife CL, Kuang J, Wills JC, Trowbridge DB, Gray P, Manning BM, Eichwald EJ, Daynes RA, Kuwada SK.

Cancer Res. 2002 Dec 1;62(23):6870-8.

8.

Interleukin-18 production following murine cardiac transplantation: correlation with histologic rejection and the induction of INF-gamma.

Affleck DG, Bull DA, Albanil A, Shao Y, Brady J, Karwande SV, Eichwald EJ, Shelby J.

J Interferon Cytokine Res. 2001 Jan;21(1):1-9.

PMID:
11177575
9.
10.

Microphthalmic mice display a B cell deficiency similar to that seen for mast and NK cells.

Roundy K, Kollhoff A, Eichwald EJ, Weis JJ, Weis JH.

J Immunol. 1999 Dec 15;163(12):6671-8.

11.

Tissue-specific consequences of the anti-adenoviral immune response: implications for cardiac transplants.

Chan SY, Li K, Piccotti JR, Louie MC, Judge TA, Turka LA, Eichwald EJ, Bishop DK.

Nat Med. 1999 Oct;5(10):1143-9.

PMID:
10502817
12.

Cytokine regulation of chronic cardiac allograft rejection: evidence against a role for Th1 in the disease process.

Piccotti JR, Li K, Chan SY, Eichwald EJ, Bishop DK.

Transplantation. 1999 Jun 27;67(12):1548-55.

PMID:
10401761
13.

Interleukin-12 (IL-12)-driven alloimmune responses in vitro and in vivo: requirement for beta1 subunit of the IL-12 receptor.

Piccotti JR, Li K, Chan SY, Eichwald EJ, Bishop DK.

Transplantation. 1999 Jun 15;67(11):1453-60.

PMID:
10385085
14.

Elastin is an essential determinant of arterial morphogenesis.

Li DY, Brooke B, Davis EC, Mecham RP, Sorensen LK, Boak BB, Eichwald E, Keating MT.

Nature. 1998 May 21;393(6682):276-80.

PMID:
9607766
15.

Alloantigen-reactive Th1 development in IL-12-deficient mice.

Piccotti JR, Li K, Chan SY, Ferrante J, Magram J, Eichwald EJ, Bishop DK.

J Immunol. 1998 Feb 1;160(3):1132-8.

16.

Distinct characteristics of resistance to Borrelia burgdorferi-induced arthritis in C57BL/6N mice.

Ma Y, Seiler KP, Eichwald EJ, Weis JH, Teuscher C, Weis JJ.

Infect Immun. 1998 Jan;66(1):161-8.

17.

Are Th2 helper T lymphocytes beneficial, deleterious, or irrelevant in promoting allograft survival?

Piccotti JR, Chan SY, VanBuskirk AM, Eichwald EJ, Bishop DK.

Transplantation. 1997 Mar 15;63(5):619-24. Review. No abstract available.

PMID:
9075827
18.

Differential effects of IL-12 receptor blockade with IL-12 p40 homodimer on the induction of CD4+ and CD8+ IFN-gamma-producing cells.

Piccotti JR, Chan SY, Li K, Eichwald EJ, Bishop DK.

J Immunol. 1997 Jan 15;158(2):643-8.

PMID:
8992979
19.
20.

A mouse model for the delta F508 allele of cystic fibrosis.

Zeiher BG, Eichwald E, Zabner J, Smith JJ, Puga AP, McCray PB Jr, Capecchi MR, Welsh MJ, Thomas KR.

J Clin Invest. 1995 Oct;96(4):2051-64.

21.

Nitric oxide production during murine Lyme disease: lack of involvement in host resistance or pathology.

Seiler KP, Vavrin Z, Eichwald E, Hibbs JB Jr, Weis JJ.

Infect Immun. 1995 Oct;63(10):3886-95.

22.

Dissociation of mouse cardiac transplant rejection and donor alloantigen-specific T cell responsiveness.

Bishop DK, DeBruyne LA, Chan S, Xu S, Eichwald EJ.

Transpl Immunol. 1995 Sep;3(3):222-8.

PMID:
8581410
23.

In vivo depletion of CD8+ T cells results in Th2 cytokine production and alternate mechanisms of allograft rejection.

Chan SY, DeBruyne LA, Goodman RE, Eichwald EJ, Bishop DK.

Transplantation. 1995 Apr 27;59(8):1155-61.

PMID:
7732563
24.
25.
26.

CD4-positive helper T lymphocytes mediate mouse cardiac allograft rejection independent of donor alloantigen specific cytotoxic T lymphocytes.

Bishop DK, Chan S, Li W, Ensley RD, Xu S, Eichwald EJ.

Transplantation. 1993 Oct;56(4):892-7.

PMID:
8212213
27.

Evidence for B-lymphocyte mitogen activity in Borrelia burgdorferi-infected mice.

Yang L, Ma Y, Schoenfeld R, Griffiths M, Eichwald E, Araneo B, Weis JJ.

Infect Immun. 1992 Aug;60(8):3033-41.

29.

Rejection criteria for the heterotopically placed mouse heart.

Xü S, Shao YL, Eichwald EJ.

Transplantation. 1992 Mar;53(3):712. No abstract available.

PMID:
1549879
30.

Bacterial translocation is prolonged in burned mice infected with cytomegalovirus.

Erickson EJ, Saffle JR, Morris SE, Eichwald EJ, Sullivan JJ, Shelby J.

J Burn Care Rehabil. 1991 Sep-Oct;12(5):454-7.

PMID:
1661288
31.

Intraperitoneal sensitization and the transplanted mouse heart.

Hisatake G, Bishop K, Shelby J, Sullivan J, Shao YL, Eichwald EJ.

Transplantation. 1991 Apr;51(4):858-61.

PMID:
2014543
32.

Expression of the protease gene HF as a marker in rejecting allogeneic murine heart transplants.

Mueller C, Shelby J, Weissman IL, Périnat-Frey T, Eichwald EJ.

Transplantation. 1991 Feb;51(2):514-7.

PMID:
1994548
33.

Functional analysis of donor-reactive T cells infiltrating heterotopic cardiac transplants: effect of anti-CD4 MAb in vivo.

Bishop DK, Shelby J, Eichwald EJ.

Transplant Proc. 1991 Feb;23(1 Pt 1):287-9. No abstract available.

PMID:
1990534
34.

Cytomegalovirus infection promotes bacterial translocation in thermally injured mice.

Erickson EJ, Saffle JR, Morris SE, Sullivan JJ, Eichwald EJ, Shelby J.

J Burn Care Rehabil. 1990 Sep-Oct;11(5):428-35.

PMID:
2174060
35.

Serum transfer, anaphylactic shock, and the role of fetal calf serum.

Araneo B, Huang K, Griffiths M, Eichwald EJ.

Transplantation. 1990 Apr;49(4):837-8. No abstract available.

PMID:
2326887
36.

Hyperacute rejection of the transplanted mouse heart.

Hisatake G, Hammond E, Ives M, Griffith J, Shelby J, Eichwald EJ.

Transplantation. 1989 Jun;47(6):996-1000.

PMID:
2660362
37.

Response to Wiberg's remarks on our article: "H-Y Antigenicity of Human Fibroblasts".

Jorgensen C, Eichwald EJ.

Hum Genet. 1989 Apr;82(1):98. No abstract available.

PMID:
2714788
38.

H-Y antigenicity of human fibroblasts.

Jorgensen C, Eichwald EJ.

Hum Genet. 1989 Jan;81(2):182.

PMID:
2643561
39.

H-Y and the transplanted mouse heart.

Ives M, Shelby J, Eichwald EJ.

Immunogenetics. 1988;27(2):137-8. No abstract available.

PMID:
3275582
40.

Arthritogenic effects of Mycoplasma arthritidis T cell mitogen in rats.

Cannon GW, Cole BC, Ward JR, Smith JL, Eichwald EJ.

J Rheumatol. 1988;15(5):735-41.

PMID:
3262748
41.

Footpad and popliteal lymph node responses to H-Y.

Eichwald EJ, Shelby J.

Transplantation. 1987 Aug;44(2):320-1. No abstract available.

PMID:
3629685
42.

The effect of antiplatelet drugs on graft atherosclerosis in rat heterotopic cardiac allografts.

Muskett A, Burton NA, Eichwald EJ, Shelby J, Hendrickson M, Sullivan JJ.

Transplant Proc. 1987 Aug;19(4 Suppl 5):74-6. No abstract available.

PMID:
3303572
43.
44.

Increased ultraviolet radiation-induced skin cancers in cyclosporine-treated mice.

Nelson EW, Eichwald EJ, Shelby J.

Transplant Proc. 1987 Feb;19(1 Pt 1):526-7. No abstract available.

PMID:
3274816
45.

Is delayed-type hypersensitivity the pathway of hyperacute rejection in transplanted mouse hearts?

Eichwald EJ, Shelby J.

Transplant Proc. 1987 Feb;19(1 Pt 1):426-7. No abstract available.

PMID:
3274798
46.

Cell-mediated hyperacute rejection. VI. Prolonged survival of heterotopic mouse heart transplants.

Shelby J, Wakely E, Jorgensen C, Eichwald EJ.

J Surg Res. 1986 Feb;40(2):133-7.

PMID:
3511323
47.

Limitations of a histologic assay for syn-, allo-, and xenogeneic H-Y antigen.

Worley R, Jorgensen C, Eichwald EJ.

J Reprod Immunol. 1985 Nov;8(2-3):121-8.

PMID:
3912502
48.

Cell-mediated hyperacute rejection. VIII. The recipient's role in adoptive transfer.

Eichwald EJ, Bernhard EJ, Jorgensen C.

Transplantation. 1985 Feb;39(2):219-20. No abstract available.

PMID:
3871543
49.

Cell-mediated hyperacute rejection. VII. Suppression by irradiation.

Eichwald EJ, Jorgensen C.

Transplantation. 1984 Aug;38(2):191-2. No abstract available.

PMID:
6380046
50.

Cell-mediated hyperacute rejection. V. Cessation of transfer effectiveness.

Eichwald EJ, Jorgensen C.

Transplantation. 1984 Jul;38(1):86-7. No abstract available.

PMID:
6234689

Supplemental Content

Loading ...
Support Center